Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2016

01-11-2016 | Original Article

Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia

Authors: Eun Sook Kim, Su Yeon Kim, Ji Young Lee, Je Ho Han, Tae Seo Sohn, Hyun Shik Son, Sung-dae Moon

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2016

Login to get access

Abstract

The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that plays an essential role in maintaining calcium homeostasis. In the present study, we analyzed the CaSR gene in a Korean family with familial hypocalciuric hypercalcemia (FHH). Genetic studies were performed by direct sequence analysis of the CaSR gene in genomic DNA obtained from peripheral leukocytes. A novel heterozygous G to T substitution at nucleotide position 1711 in exon 6, resulting in the G571W mutation, was identified in the CaSR gene in a 26-year-old female with asymptomatic hypercalcemia, a low calcium/creatinine clearance ratio, and normal intact parathyroid hormone. To study CaSR expression, the mutation was introduced by site-directed mutagenesis into a wild-type (WT) CaSR-expressing pCR3.1 vector, and COS-7 cells were transfected with either the WT or mutant CaSR-containing vector. Transfected cells loaded with Fura-2/AM, a fluorescent indicator of Ca2+, were assessed for CaSR function by the change in intracellular calcium [as measured by the 340 nm/380 nm fluorescence intensity ratio (F340/F380)] made in response to challenge with extracellular Ca2+. Both WT and G571W cells had equivalent amounts of CaSR protein in the cell membrane. However, after challenge with extracellular Ca2+, cells transfected with G571W CaSR responded with a lower F340/F380 ratio than those transfected with WT CaSR and showed decreased sensitivity to extracellular Ca2+ concentrations. The G571W mutation had therefore impaired the CaSR function. In conclusion, we identified a novel loss-of-function mutation, G571W, in the CaSR gene in a Korean family with FHH.
Literature
1.
go back to reference Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, Bruneval P, Mandet C, Christensen EI, Faure H, Cheval L, Laghmani K, Collet C, Eladari D, Dodd RH, Ruat M, Houillier P (2012) PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 122:3355–3367CrossRefPubMedPubMedCentral Loupy A, Ramakrishnan SK, Wootla B, Chambrey R, de la Faille R, Bourgeois S, Bruneval P, Mandet C, Christensen EI, Faure H, Cheval L, Laghmani K, Collet C, Eladari D, Dodd RH, Ruat M, Houillier P (2012) PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 122:3355–3367CrossRefPubMedPubMedCentral
3.
go back to reference Chattopadhyay N, Brown EM (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89:189–202CrossRefPubMed Chattopadhyay N, Brown EM (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89:189–202CrossRefPubMed
4.
go back to reference Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed
5.
go back to reference Christensen SE, Nissen PH, Vestergaard P, Mosekilde L (2011) Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes 18:359–370CrossRefPubMed Christensen SE, Nissen PH, Vestergaard P, Mosekilde L (2011) Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes 18:359–370CrossRefPubMed
6.
go back to reference Ito S, Kume H, Naruse K, Kondo M, Takeda N, Iwata S, Hasegawa Y, Sokabe M (2008) A novel Ca2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells. Am J Respir Cell Mol Biol 38:407–413CrossRefPubMed Ito S, Kume H, Naruse K, Kondo M, Takeda N, Iwata S, Hasegawa Y, Sokabe M (2008) A novel Ca2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells. Am J Respir Cell Mol Biol 38:407–413CrossRefPubMed
7.
go back to reference Chattopadhyay N, Brown E (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89:189–202CrossRefPubMed Chattopadhyay N, Brown E (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89:189–202CrossRefPubMed
8.
go back to reference Brown MDEM, Pollak MDM, Hebert MDSC (1998) The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49:15–29CrossRefPubMed Brown MDEM, Pollak MDM, Hebert MDSC (1998) The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49:15–29CrossRefPubMed
9.
go back to reference Lia Baldini A-S, Magdelaine C, Al Nizou, Airault C, Salles J-P, Moulin P, Delemer B, Aitouares M, Bt Funalot, Sturtz F, Lienhardt Roussie A (2013) Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p. N802 on receptor activity. Eur J Endocrinol 168:K27–K34CrossRefPubMed Lia Baldini A-S, Magdelaine C, Al Nizou, Airault C, Salles J-P, Moulin P, Delemer B, Aitouares M, Bt Funalot, Sturtz F, Lienhardt Roussie A (2013) Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p. N802 on receptor activity. Eur J Endocrinol 168:K27–K34CrossRefPubMed
10.
go back to reference Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV (1996) Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 45:675–680CrossRef Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV (1996) Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 45:675–680CrossRef
11.
go back to reference Volpe A, Guerriero A, Marchetta A, Caramaschi P, Furlani L (2009) Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis. Joint Bone Spine 76:708–710CrossRefPubMed Volpe A, Guerriero A, Marchetta A, Caramaschi P, Furlani L (2009) Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis. Joint Bone Spine 76:708–710CrossRefPubMed
12.
go back to reference Rubin M, Bilezikian J, McMahon D, Jacobs T, Shane E, Siris E, Udesky J, Silverberg S (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462–3470CrossRefPubMedPubMedCentral Rubin M, Bilezikian J, McMahon D, Jacobs T, Shane E, Siris E, Udesky J, Silverberg S (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462–3470CrossRefPubMedPubMedCentral
13.
go back to reference Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D, Hendy GN (2007) Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab 92:2616–2623CrossRefPubMed Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D, Hendy GN (2007) Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. J Clin Endocrinol Metab 92:2616–2623CrossRefPubMed
14.
go back to reference Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry Keene D, Learoyd D, Robinson B, Birdsey P, Mackenzie E, Teh BT, Prins JB, Cardinal J (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41:155–160CrossRefPubMedPubMedCentral Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry Keene D, Learoyd D, Robinson B, Birdsey P, Mackenzie E, Teh BT, Prins JB, Cardinal J (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41:155–160CrossRefPubMedPubMedCentral
15.
go back to reference Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, Trivedi S, Hellman P, Brown EM, Dahl N, Rastad J (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85:2042–2047PubMed Carling T, Szabo E, Bai M, Ridefelt P, Westin G, Gustavsson P, Trivedi S, Hellman P, Brown EM, Dahl N, Rastad J (2000) Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 85:2042–2047PubMed
16.
go back to reference Rus R, Haag C, Bumke Vogt C, Bhr V, Mayr B, Mhlig M, Schulze E, Frank Raue K, Raue F, Schfl C (2008) Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab 93:4797–4803CrossRefPubMed Rus R, Haag C, Bumke Vogt C, Bhr V, Mayr B, Mhlig M, Schulze E, Frank Raue K, Raue F, Schfl C (2008) Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab 93:4797–4803CrossRefPubMed
17.
go back to reference Hendy GN, Canaff L, Newfield RS, Tripto-Shkolnik L, Wong BY, Lee BS, Cole DE (2014) Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations. J Clin Endocrinol Metab 99:E1311–E1315CrossRefPubMed Hendy GN, Canaff L, Newfield RS, Tripto-Shkolnik L, Wong BY, Lee BS, Cole DE (2014) Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations. J Clin Endocrinol Metab 99:E1311–E1315CrossRefPubMed
18.
go back to reference Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, Gregory L, Rimmer AJ, Rust N, Graham U, Morrison PJ, Hunter SJ, Whyte MP, McVean G, Buck D, Thakker RV (2013) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 45:93–97CrossRefPubMed Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, Gregory L, Rimmer AJ, Rust N, Graham U, Morrison PJ, Hunter SJ, Whyte MP, McVean G, Buck D, Thakker RV (2013) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 45:93–97CrossRefPubMed
19.
go back to reference Tenhola S, Hendy GN, Valta H, Canaff L, Lee BS, Wong BY, Valimaki MJ, Cole DE, Makitie O (2015) Cinacalcet treatment in an adolescent with concurrent 22q11.2 deletion syndrome and FHH3 caused by AP2S1 mutation. J Clin Endocrinol Metab; 100:2015−1518 Tenhola S, Hendy GN, Valta H, Canaff L, Lee BS, Wong BY, Valimaki MJ, Cole DE, Makitie O (2015) Cinacalcet treatment in an adolescent with concurrent 22q11.2 deletion syndrome and FHH3 caused by AP2S1 mutation. J Clin Endocrinol Metab; 100:2015−1518
Metadata
Title
Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia
Authors
Eun Sook Kim
Su Yeon Kim
Ji Young Lee
Je Ho Han
Tae Seo Sohn
Hyun Shik Son
Sung-dae Moon
Publication date
01-11-2016
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2016
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-015-0713-z

Other articles of this Issue 6/2016

Journal of Bone and Mineral Metabolism 6/2016 Go to the issue

List of Reviewers 2015-2016

List of reviewers 2015–2016

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.